Sophie J. F. van der Spek

Ms. Sophie J. F. van der Spek

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2022 in Cells
Verified
Journal Article
Open access
PDF file
SSSophie J. F. van der Spek
Sophie J. F. van der Spek
NPNikhil J. Pandya
Nikhil J. Pandya
FKFrank Koopmans
Frank Koopmans
IPIryna Paliukhovich
Iryna Paliukhovich
RSRoel van der Schors
Roel van der Schors
Ka Wan LiKa Wan Li
Ka Wan Li
The AMPA glutamate receptor (AMPAR) is the major type of synaptic excitatory ionotropic receptor in the brain. AMPARs have four different subunits, GluA1–4 (each encoded by different genes, Gria1, Gria2, Gria3 and Gria4), that can form distinct tetrameric assemblies. The most abundant AMPAR subtypes in the hippocampus are GluA1/2 and GluA2/3 heterotetramers. Each subtype contributes differentially to mechanisms of synaptic plasticity, which may be in part caused by how these receptors are regulated by specific associated proteins. A broad range of AMPAR interacting proteins have been identified, including the well-studied transmembrane AMPA receptor regulatory proteins TARP-γ2 (also known as Stargazin) and TARP-γ8, Cornichon homolog 2 (CNIH-2) and many others. Several interactors were shown to affect biogenesis, AMPAR trafficking, and channel properties, alone or in distinct assemblies, and several revealed preferred binding to specific AMPAR subunits. To date, a systematic specific interactome analysis of the major GluA1/2 and GluA2/3 AMPAR subtypes separately is lacking. To reveal interactors belonging to specific AMPAR subcomplexes, we performed both expression and interaction proteomics on hippocampi of wildtype and Gria1- or Gria3 knock-out mice. Whereas GluA1/2 receptors co-purified TARP-γ8, synapse differentiation-induced protein 4 (SynDIG4, also known as Prrt1) and CNIH-2 with highest abundances, GluA2/3 receptors revealed strongest co-purification of CNIH-2, TARP-γ2, and Noelin1 (or Olfactomedin-1). Further analysis revealed that TARP-γ8-SynDIG4 interact directly and co-assemble into an AMPAR subcomplex especially at synaptic sites. Together, these data provide a framework for further functional analysis into AMPAR subtype specific pathways in health and disease.

24 June 2021 in Cells
Verified
Journal Article
Open access
PDF file
SSSophie J. F. van der Spek
Sophie J. F. van der Spek
MGMiguel A Gonzalez-Lozano
Miguel A Gonzalez-Lozano
FKFrank Koopmans
Frank Koopmans
SMSuzanne S. M. Miedema
Suzanne S. M. Miedema
IPIryna Paliukhovich
Iryna Paliukhovich
Ka Wan LiKa Wan Li
Ka Wan Li
Alzheimer’s disease (AD) is the most common neurodegenerative disorder in the human population, for which there is currently no cure. The cause of AD is unknown; however, the toxic effects of amyloid-β (Aβ) are believed to play a role in its onset. To investigate this, we examined changes in global protein levels in a hippocampal synaptosome fraction of the Amyloid Precursor Protein swe/Presenelin 1 dE9 (APP/PS1) mouse model of AD at 6 and 12 months of age (moa). Data independent acquisition (DIA), or Sequential Window Acquisition of all THeoretical fragment-ion (SWATH), was used for a quantitative label-free proteomics analysis. We first assessed the usefulness of a recently improved directDIA workflow as an alternative to conventional DIA data analysis using a project-specific spectral library. Subsequently, we applied directDIA to the 6- and 12-moa APP/PS1 datasets and applied the Mass Spectrometry Downstream Analysis Pipeline (MS-DAP) for differential expression analysis and candidate discovery. We observed most regulation at 12-moa, in particular of proteins involved in Aβ homeostasis and microglial-dependent processes, like synaptic pruning and the immune response, such as APOE, CLU and C1QA-C. All proteomics data are available via ProteomeXchange with identifier PXD025777.

31 July 2023 in Human Molecular Genetics
Verified
Journal Article
Closed access
PDF file
CWChelsea J Webber
Chelsea J Webber
CMCaroline N Murphy
Caroline N Murphy
ARAlejandro N Rondón-Ortiz
Alejandro N Rondón-Ortiz
SSSophie J. F. van der Spek
Sophie J. F. van der Spek
EKElena X Kelly
Elena X Kelly
BWBenjamin Wolozin
Benjamin Wolozin
Aggregation of TAR DNA-binding protein 43 kDa (TDP-43) is thought to drive the pathophysiology of amyotrophic lateral sclerosis and some frontotemporal dementias. TDP-43 is normally a nuclear protein that in neurons translocates to the cytoplasm and can form insoluble aggregates upon activation of the integrated stress response (ISR). Viruses evolved to control the ISR. In the case of Herpesvirus 8, the protein ORF57 acts to bind protein kinase R, inhibit phosphorylation of eIF2α and reduce activation of the ISR. We hypothesized that ORF57 might also possess the ability to inhibit aggregation of TDP-43. ORF57 was expressed in the neuronal SH-SY5Y line and its effects on TDP-43 aggregation characterized. We report that ORF57 inhibits TDP-43 aggregation by 55% and elicits a 2.45-fold increase in the rate of dispersion of existing TDP-43 granules. These changes were associated with a 50% decrease in cell death. Proteomic studies were carried out to identify the protein interaction network of ORF57. We observed that ORF57 directly binds to TDP-43 as well as interacts with many components of the ISR, including elements of the proteostasis machinery known to reduce TDP-43 aggregation. We propose that viral proteins designed to inhibit a chronic ISR can be engineered to remove aggregated proteins and dampen a chronic ISR.

6 July 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
WLWeiwei Lin
Weiwei Lin
SPSadhna Phanse
Sadhna Phanse
SSSophie J. F. van der Spek
Sophie J. F. van der Spek
NLNoah Lampl
Noah Lampl
MSMorgan C. Stephens
Morgan C. Stephens
BWBenjamin Wolozin
Benjamin Wolozin
SUMMARY: Neurodegenerative disease is marked not just by loss of proteins or cells, but by dynamic rewiring of macromolecular interaction networks that precede and drive pathology. Here, we present the first temporally resolved, systems-scale map of multi-protein complex remodeling in a tauopathy model, integrating co-fractionation mass spectrometry, quantitative phosphoproteomics, and machine learning to decode phosphorylation-dependent shifts in protein interactomes across disease progression. This interactomic atlas identifies functionally validated assemblies—including MAPT-Dpysl2 and Cyfip1-actin complexes—that modulate early disease phenotypes in vivo. By revealing how phosphorylation tunes macromolecular complex architecture and function, this work reframes tauopathy as a disease of dynamic network instability, and establishes a generalizable framework for early detection and mechanistic dissection of neurodegeneration.

6 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
JLJenna L. Libera
Jenna L. Libera
JHJunming Hu
Junming Hu
TNTuyet-Anh Nguyen
Tuyet-Anh Nguyen
ZWZihan Wang
Zihan Wang
SSSophie J. F. van der Spek
Sophie J. F. van der Spek
BWBenjamin Wolozin
Benjamin Wolozin
Dysregulated RNA metabolism is a significant feature of Alzheimer’s disease (AD), yet how post-transcriptional RNA modifications like N 6 -methyladenosine (m 6 A) are altered in AD is unknown. Here, we performed d eamination a djacent to R NA modification targets (DART-seq) on human dorsolateral prefrontal cortices to assess changes in m 6 A with nucleotide resolution. In non-AD brains, m 6 A sites increased with age, predominantly within the 3′UTR of transcripts encoding tripartite synapse proteins. In contrast, AD brains lost the age-associated m 6 A site increase and exhibited global hypomethylation of transcripts, including MAPT and APP . Hypomethylated genes involved with GABAergic signaling, glutamate transport, and ubiquitin-mediated proteolysis exhibited reduced expression, connecting m 6 A to synaptic excitotoxicity and disrupted proteostasis in AD. Site-specific m 6 A levels were linked with GABRA1 expression and protein levels, but this relationship was abolished in AD. Our findings provide insight into post-transcriptional mechanisms of dysregulated RNA metabolism in AD that are related to aging and GABAergic regulation. HIGHLIGHTS: With age, the number of m 6 A sites increases among Control cases (lacking AD pathology) but remains unchanged in AD cases. Transcripts are globally hypomethylated in AD cases. Hypomethylation is linked to decreased mRNA expression of transcripts related to synaptic and proteostatic function in AD. 3’UTR-localized m 6 A sites lack typical association with transcript metabolism of GABRA1 in AD. Graphical

3 August 2024 in Journal of Biological Chemistry
Verified
Journal Article
Open access
ARAlejandro N. Rondón-Ortiz
Alejandro N. Rondón-Ortiz
LZLushuang Zhang
Lushuang Zhang
PAPeter E.A. Ash
Peter E.A. Ash
ABAvik Basu
Avik Basu
SPSambhavi Puri
Sambhavi Puri
BWBenjamin Wolozin
Benjamin Wolozin
Sequestosome1 (SQSTM1) is an autophagy receptor that mediates the degradation of intracellular cargo, including protein aggregates, through multiple protein interactions. These interactions form the SQSTM1 protein network, and these interactions are mediated by SQSTM1 functional interaction domains, which include LIR, PB1, UBA, and KIR. Technological advances in cell biology continue to expand our knowledge of the SQSTM1 protein network and the relationship between the actions of the SQSTM1 protein network in cellular physiology and disease states. Here we apply proximity profile labeling to investigate the SQSTM1 protein interaction network by fusing TurboID with the human protein SQSTM1 (TurboID::SQSTM1). This chimeric protein displayed well-established SQSTM1 features including production of SQSTM1 intracellular bodies, binding to known SQSTM1 interacting partners, and capture of novel SQSTM1 protein interactors. Strikingly, aggregated tau protein altered the protein interaction network of SQSTM1 to include many stress-associated proteins. We demonstrate the importance of the PB1 and/or UBA domains for binding network members, including the K18 domain of tau. Overall, our work reveals the dynamic landscape of the SQSTM1 protein network and offers a resource to study SQSTM1 function in cellular physiology and disease state.